Literature DB >> 1899902

The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

C Nanoff1, K A Jacobson, G L Stiles.   

Abstract

Agonist binding to the A2 adenosine receptor (A2AR) and its regulation by guanine nucleotides was studied using the newly developed radioligand 125I-2-[4-(2-[2-[(4-aminophenyl)methylcarbonylamino] ethylaminnocarbonyl]ethyl)phenyl]ethylamino-5'-N- ethylcarboxamidoadenosine (125I-PAPA-APEC) and its photoaffinity analog 125I-azido-PAPA-APEC. A single protein of Mr 45,000, displaying the appropriate A2AR pharmacology, is labeled in membranes from bovine striatum, PC12 cells, and frog erythrocytes. In DDT1 MF2 cells the labeled protein has a slightly lower molecular weight. Incorporation of 125I-azido-PAPA-APEC into membranes from rabbit striatum, however, reveals two specifically labeled peptides (Mr approximately 47,000 and 38,000), both of which display A2AR pharmacology. Inhibition of protease activity leads to a decrease in the amount of the Mr 38,000 protein, with only the Mr 47,000 protein remaining. This suggests that the Mr 38,000 peptide is a proteolytic product of the Mr 47,000 A2AR protein. In membranes containing the intact undigested A2AR protein, guanine nucleotides induce a small to insignificant decrease in agonist binding, which is atypical of stimulatory GS-coupled receptors. This minimal effect is observed in rabbit striatal membranes prepared in the presence of protease inhibitors, as well as in the other tissues studied. Binding to rabbit striatal membranes that possess the partially digested receptor protein, however, reveals a 50% reduction in maximal specific agonist binding upon addition of guanine nucleotides. Inhibition of proteolysis in rabbit striatum, on the other hand, results in a diminished ability of guanine nucleotides to regulate agonist binding. Thus, the enhanced effectiveness of guanine nucleotides in rabbit striatal membranes is associated with the generation of the Mr 38,000 peptide fragment. Guanosine 5'-(beta,gamma-imido)triphosphate reduces photoaffinity labeling by 55% in the Mr 38,000 protein, whereas the labeling is decreased by only 28% in the Mr 47,000 receptor protein. Our data, therefore, suggest that, unless proteolysis occurs, the A2AR in all tissues studied is tightly associated with the GS protein and displays minimal guanine nucleotide modulation of agonist binding, which makes the A2AR an atypical stimulatory receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899902      PMCID: PMC3463105     

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  Glycoprotein nature of the A2-adenosine receptor binding subunit.

Authors:  W W Barrington; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1990-08       Impact factor: 4.436

2.  Adenosine receptors and beyond: molecular mechanisms of physiological regulation.

Authors:  G L Stiles
Journal:  Clin Res       Date:  1990-01

Review 3.  Cardiovascular purinoceptors.

Authors:  R A Olsson; J D Pearson
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Purification and characterization of the adenosine A2-like binding site from human placental membrane.

Authors:  K A Hutchison; I H Fox
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

6.  Agonist derived molecular probes for A2 adenosine receptors.

Authors:  K A Jacobson; L K Pannell; X D Ji; M F Jarvis; M Williams; A J Hutchison; W W Barrington; G L Stiles
Journal:  J Mol Recognit       Date:  1989-12       Impact factor: 2.137

7.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

8.  Purification of A1 adenosine receptor from rat brain membranes.

Authors:  H Nakata
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

9.  Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.

Authors:  W W Barrington; K A Jacobson; A J Hutchison; M Williams; G L Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

10.  Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.

Authors:  V Ramkumar; W W Barrington; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

View more
  23 in total

1.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

2.  Adenosine receptors in post-mortem human brain.

Authors:  S James; J H Xuereb; R Askalan; P J Richardson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

Review 4.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

5.  Constitutive activity of the A2A adenosine receptor and compartmentalised cyclic AMP signalling fine-tune noradrenaline release.

Authors:  Edin Ibrisimovic; Helmut Drobny; Qiong Yang; Thomas Höfer; Stefan Boehm; Christian Nanoff; Klaus Schicker
Journal:  Purinergic Signal       Date:  2012-04-05       Impact factor: 3.765

6.  Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

8.  125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

Authors:  T M Palmer; S M Poucher; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

9.  Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE).

Authors:  Aurora R Barros-Barbosa; Fátima Ferreirinha; Ângela Oliveira; Marina Mendes; M Graça Lobo; Agostinho Santos; Rui Rangel; Julie Pelletier; Jean Sévigny; J Miguel Cordeiro; Paulo Correia-de-Sá
Journal:  Purinergic Signal       Date:  2016-09-20       Impact factor: 3.765

10.  Molecular Characterization of A(1) and A(2a) Adenosine Receptors.

Authors:  Kenneth A Jacobson; Philip J M van Galen; Xiao-Duo Ji; Vickram Ramkumar; Mark E Olah; Gary L Stiles
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.